CombiMatrix Posts 27 Percent Q4 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Wednesday that its fourth quarter revenues jumped 27 percent, driven by sales of its prenatal and miscarriage analysis tests.

The firm reported total revenues of $2.2 million for the three months ended Dec. 31, 2014, up from $1.8 million for the fourth quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.